🕵️ Envoy Medical, Inc. ($COCH)
SEC insider & ownership activity, last 12 months · CIK 1840877 · every row links its SEC filing
Over the last 12 months insiders bought $8.2M with no open-market selling against it. Glen A. Taylor bought $7.5M in discretionary trades (Feb). Glen A. Taylor added 44.2% → 84.8%. 2 red-flag 8-Ks in the window, most recently Delisting notice (3.01), May 19, 2026.
Insider flow
6 buyers, $8.2M (18 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Glen A. Taylor | 3 | $7.5M | 0 | – | Feb 12, 2026 |
| Brynelsen Charles | 3 | $400K | 0 | – | Feb 12, 2026 |
| Patel Mona Chetan | 3 | $125K | 0 | – | Feb 12, 2026 |
| Potashnick Robert | 3 | $85K | 0 | – | Feb 12, 2026 |
| Kantor Susan | 3 | $38K | 0 | – | Feb 12, 2026 |
| Brent T. Lucas | 3 | $25K | 0 | – | Feb 12, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Glen A. Taylor | 84.8% | 13D | Feb 12, 2026 | filing ↗ | |
| ANZU SPAC GP I LLC | 11.3% | Class A | 13D | Sep 29, 2023 | filing ↗ |
| Bleichroeder LP | 10.0% | 13G | May 14, 2026 | filing ↗ | |
| Bleichroeder Holdings LLC | 10.0% | 13G | May 14, 2026 | filing ↗ | |
| Andrew Gundlach | 10.0% | 13G | May 14, 2026 | filing ↗ | |
| Nantahala Capital Management, LLC | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Wilmot B. Harkey | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| Daniel Mack | 10.0% | 13G | May 15, 2026 | filing ↗ | |
| ALTA Partners LLC | 8.3% | 13G | Aug 21, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | Jun 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 24, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 19, 2026 | filing ↗ |
| Delisting notice (3.01) | May 19, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 12, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |
| Auditor change (4.01) | Mar 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 25, 2026 | filing ↗ |
| Earnings (2.02) | Mar 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 23, 2026 | filing ↗ |
| Delisting notice (3.01) | Feb 23, 2026 | filing ↗ |
| Other events (8.01) | Feb 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 23, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 11, 2026 | filing ↗ |
| Other events (8.01) | Feb 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 5, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 16, 2025 | filing ↗ |
| Shareholder vote (5.07) | Nov 26, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 26, 2025 | filing ↗ |